Researchers conducted a study to assess the clinical efficacy, safety, and tolerability of Paxlovid (PF-07321332/ritonavir), an oral SARS-CoV-2 Mpro inhibitor candidate for the treatment of COVID-19.
Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.
Researchers conducted a study to determine the effect of patient characteristics and racial/ethnic disparities on outcomes of SARS-CoV-2 infection.
This ad hoc survey focused on changes in sexual behaviors and utilization of and access to sexual health services by MSM during the COVID-19 pandemic.
The mucocutaneous features seen in hospitalized children with MIS-C and how these findings are associated with the onset of systemic symptoms are characterized.
The study authors describe the first use of valganciclovir treatment in lower-income countries for patients with CMVR, advanced HIV disease, and profound immunosuppression.
